Compound ID | 775
Class: Protein synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits the elongation Factor Tu. Effective against Gram positive staphylocci and enterococci |
| Description: | N'-p-octyloxybenzylglycyl-vancomycin |
| Institute where first reported: | Chiron Corp. (Novartis, Switzerland) |
| Year first mentioned: | 2005 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |